These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36536076)

  • 1. Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway.
    Sun HY; Wu J; Wang R; Zhang S; Xu H; Kaznacheyeva Е; Lu XJ; Ren HG; Wang GH
    Acta Pharmacol Sin; 2023 Jun; 44(6):1135-1148. PubMed ID: 36536076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.
    Gu C; Wang F; Zhang YT; Wei SZ; Liu JY; Sun HY; Wang GH; Liu CF
    Aging Cell; 2021 Jun; 20(6):e13375. PubMed ID: 33964119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effects of endotoxin tolerance on peripheral lipopolysaccharide-induced neuroinflammation and dopaminergic neuronal injury.
    Yao L; Li P; Chen Q; Hu A; Wu Y; Li B
    Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):326-337. PubMed ID: 35260024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial SIX2 suppresses lipopolysaccharide (LPS)-induced neuroinflammation by up-regulating FXYD2 expression.
    Cao XY; Liu Y; Kan JS; Huang XX; Kambey PA; Zhang CT; Gao J
    Brain Res Bull; 2024 Jun; 212():110970. PubMed ID: 38688414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo.
    Lee SL; Tu SC; Hsu MY; Chin TY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
    Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
    Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
    Wang L; Bai Y; Tao Y; Shen W; Zhou H; He Y; Wu H; Huang F; Shi H; Wu X
    Chin J Nat Med; 2023 Sep; 21(9):710-720. PubMed ID: 37777320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats.
    Du ZR; Gu Y; Xie XM; Zhang M; Jiang GY; Chen WF
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105989. PubMed ID: 34478828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
    Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
    Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
    Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation.
    Kang S; Piao Y; Kang YC; Lim S; Pak YK
    Biomed Pharmacother; 2022 Jan; 145():112389. PubMed ID: 34775235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
    He D; Huang B; Fu S; Li Y; Ran X; Liu Y; Chen G; Liu J; Liu D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.